Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands

ConclusionXC8 was safe and well tolerated. A phase 2 study is being performed to further evaluate the potential role of XC8 in asthma treatment.Trial registrationClinicalTrials.gov, NCT02882217.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research